| |
 |
| |
ThromboGenics is a biopharmaceutical company focused on the development of therapeutics
for conditions related to the vascular system. The Company has useds ... more » |
|
|
|
|
 |
|
| |
ThromboGenics has developed a strong pipeline of products for the treatment of a broad range of conditions related to the vasculature, including visual disorders, ... more » |
|
|
|
|
 |
|
| |
Apr 9, 2008
ThromboGenics announces that it has completed patient enrolment for its Phase II MITI IV study... more »
ThromboGenics kondigt de voltooiing aan van de patiëntenrekrutering voor zijn Fase II MITI IV studie... meer » |
|
|
|